scPharmaceuticals Inc.
SCPH
$2.57
$0.020.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 21.18% | 24.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 21.18% | 24.48% | |||
| Cost of Revenue | 19.75% | 43.96% | |||
| Gross Profit | 21.89% | 16.70% | |||
| SG&A Expenses | 0.25% | 21.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.14% | 25.29% | |||
| Operating Income | 9.94% | -25.74% | |||
| Income Before Tax | 46.32% | -105.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 46.32% | -105.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 46.32% | -105.41% | |||
| EBIT | 9.94% | -25.74% | |||
| EBITDA | 9.93% | -25.75% | |||
| EPS Basic | 53.25% | -71.99% | |||
| Normalized Basic EPS | 55.23% | -78.36% | |||
| EPS Diluted | 53.25% | -71.99% | |||
| Normalized Diluted EPS | 55.23% | -78.36% | |||
| Average Basic Shares Outstanding | 14.83% | 19.43% | |||
| Average Diluted Shares Outstanding | 14.83% | 19.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||